CytomX Therapeutics, Inc. (NASDAQ:CTMX) last session’s volume of 0.13 million shares was lower than its average volume of 0.26 million shares. The stock, after opening at $17.25, hit $16.75 through the close by scoring -2.28%.CytomX Therapeutics, Inc. (CTMX) Analyst Opinion
CytomX Therapeutics, Inc. has a consensus outperform rating from 6 Wall Street analysts, and the number of shares currently sold short amount to at least 2.09% of shares outstanding. The stock spiked 11% last month and is up 52.41 this year. Wall Street is only getting more bullish on the stock, with 5 of analysts who cover CTMX having a buy-equivalent rating. Analysts have placed a $27.25 price target on CytomX Therapeutics, Inc., suggesting a 62.69% gain from recent close. It’s currently trading about -16.33% below its 52-week high.CytomX Therapeutics, Inc. Earnings Surprise
CytomX Therapeutics, Inc. (CTMX) surprised the stock market in its last reported earnings when it earned -$0.39 a piece versus the consensus-estimated -$0.43. Its revenue totaled $3.59 million up 4.06% from the previous quarter. Expect increased sales in the current quarter as well. As per the consensus estimate, the company’s year-on-year revenue growth is expected to be at 80.18% during the period. Last year, it had about $2.22 million of revenue.
This stock (CTMX) is ahead of its 52-week low with 84.07%. Its last month’s stock price volatility remained 4.64% which for the week stands at 6.17%. The share price has moved backward from its 20 days moving average, trading at a distance of -1.03% and stays 18.33% away from its 50 days moving average. Over the last five days, shares have faced -1.59% losses and now is up 34.13% since hitting its 200-day moving average of $12.97. CytomX Therapeutics, Inc. (CTMX) has made its way to a 12-month gain of 25.37%.
Turning to Intrepid Potash, Inc. (NYSE:IPI), its shares were trading at $1.72 a retreat of $-0.07, on the trading floor. The stock, after opening at $1.79, touched a high of $1.8 before paring much of its gains. So far, analysts are sticking with their bearish recommendations with the consensus call at 3.5. Intrepid Potash, Inc. has 0 buy ratings, 2 holds and 0 sells even after the stock tumbled -43.42% from its high of $3.04 to a $207.66 million market value through April 10, 2017.Intrepid Potash, Inc. (IPI) Consensus Price Target
The company’s consensus rating on Reuter’s scale improved from 3.4 to 3.5 during a month. Analysts set a 12-month price target of $2 a share. The target implies a 16.28% spike from where the shares are currently trading. Also, the current price highlights a discount of 16.28% to analysts’ high consensus price target.Intrepid Potash, Inc. EPS Forecast
The earnings of Intrepid Potash, Inc. (IPI) are forecasted by the analysts to move at -$0.1 in current quarter, from -$0.22 a year-ago quarter. This quarter analysts say they expect sales to move at $35.55 million — lower from $73.28 million the year before.Intrepid Potash, Inc. (NYSE:IPI) Intraday Trading
The counter witnessed a trading volume of 0.55 million shares versus an average volume of 1.86 million shares during last trading session. Its last month’s stock price volatility remained 8.51% which for the week approaches 8.09. The lowest price the stock reached on Monday was $1.7 and compares with the $0.85 52-week low. The stock recovered 102.35% since its low point and has performed -17.31% year-to-date.